Episiotomy WoundNCT07572617
Comparison of Absorbable Synthetic and Catgut Suture Material in Episiotomy Repair
A study testing Absorbable synthetic suture and Catgut in people with Episiotomy Wound, run by Muhammad Aamir Latif at 1 site in Pakistan.
Trial summary
There is paucity of local literature regarding the most appropriate absorbable suture material for episiotomy repair despite the fact that tremendous number of women undergo the procedure daily. Read more about this study
- Who is it for?
- Ages 20 to 40 years, women only
- Conditions the study is for
- Episiotomy Wound
- What is being tested?
- Absorbable synthetic suture and Catgut
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 126 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Mar 2025to 31 Aug 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Pregnant women
- Aged 20-40 years
- Gestational age 37-42 weeks (assessed on last menstrual period)
Who cannot join
- Premature rupture of membranes
- Preterm vaginal delivery
- Twin gestation
- Operative delivery
- Vulval hematoma
- Vaginal tears
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Comparison of the Outcome (in Terms of Healing) Between Absorbable Synthetic and Catgut Suture Material in Episiotomy Repair.
There is paucity of local literature regarding the most appropriate absorbable suture material for episiotomy repair despite the fact that tremendous number of women undergo the procedure daily. Hence, the current study was planned aiming to compare the outcome between absorbable synthetic and catgut suture material in episiotomy repair.
Read the detailed description
Chromic catgut remains a commonly used suture material in the country. Based on these results, practical recommendations can be made for routine practice guidelines. These guidelines should provide patients with more effective suture materials that promote early healing, ultimately aiming to reduce morbidity within the local population.
- Conditions
- Episiotomy Wound
- Being tested
- Absorbable synthetic suture, Catgut
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Absorbable synthetic sutureProcedure or surgery
Patients went through suturing with absorbable synthetic suture.
CatgutProcedure or surgery
Patients went through suturing with catgut.
| Study group | Role | What they receive |
|---|---|---|
| Group-A | Experimental | Patients went through suturing with absorbable synthetic suture. Receives: Procedure: Absorbable synthetic suture |
| Group-B | Experimental | Patients went through suturing with catgut. Receives: Procedure: Catgut |
What is being measured
The primary outcome is the main question the study is designed to answer.
Post-operative pain
Pain was measured on the visual analog scale, with 0 as no pain, 1-3 as mild, 4-7 as moderate, and 8-10 as severe pain. Frequencies of all categories were noted.
Measured: 6 weeks
Wound infection
The frequency of patients developing a wound infection was noted.
Measured: 6 weeks
Wound dehiscence
The frequency of patients who experienced episiotomy wound ruptures and opened up along a surgical incision was noted.
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 May 2026
- Study start1 Mar 2025
- Primary completion31 Aug 2025
- Study completion31 Aug 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Episiotomy WoundStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 126 participants (actual)
Sponsor and investigators
- Lead sponsor
- Muhammad Aamir Latif
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Muhammad Aamir Latif, RESnTEC, Institute of Research
- Investigators
- Komal Iqbal, Principal investigator, Sadiq Abbasi Hospital, Bahawalpur, PakistanSaba Nadeem, FCPS, Study director, Sadiq Abbasi Hospital, Bahawalpur, Pakistan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07572617
- Sponsor's protocol ID
- Dr-Komal-QAMC
- Status last verified
- May 2026
- First submitted
- 1 May 2026
- Last updated
- 7 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Data can be shared on a reasonable request.
Study at a glance
From the registry record, last updated by the sponsor on 7 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of the Outcome (in Terms of Healing) Between Absorbable Synthetic and Catgut Suture Material in Episiotomy Repair.
- ClinicalTrials.gov ID
- NCT07572617
- Acronym / sponsor ID
- Dr-Komal-QAMC
- Conditions
- Episiotomy Wound
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 126 participants (actual)
- Lead sponsor
- Muhammad Aamir LatifUniversity, hospital or other
- Study start
- 1 Mar 2025 (actual)
- Primary completion
- 31 Aug 2025 (actual)
- Study completion
- 31 Aug 2025 (actual)
- First posted
- 7 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
There is paucity of local literature regarding the most appropriate absorbable suture material for episiotomy repair despite the fact that tremendous number of women undergo the procedure daily. Hence, the current study was planned aiming to compare the outcome between absorbable synthetic and catgut suture material in episiotomy repair.
Detailed description
Chromic catgut remains a commonly used suture material in the country. Based on these results, practical recommendations can be made for routine practice guidelines. These guidelines should provide patients with more effective suture materials that promote early healing, ultimately aiming to reduce morbidity within the local population.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group-A | Experimental | Procedure: Absorbable synthetic suturePatients went through suturing with absorbable synthetic suture. |
| Group-B | Experimental | Procedure: CatgutPatients went through suturing with catgut. |
Who may qualify
- Ages
- 20 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Pregnant women
- Aged 20-40 years
- Gestational age 37-42 weeks (assessed on last menstrual period)
Key exclusion criteria (6 listed)
- Premature rupture of membranes
- Preterm vaginal delivery
- Twin gestation
- Operative delivery
- Vulval hematoma
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Absorbable synthetic suturePatients went through suturing with absorbable synthetic suture. | Procedure or surgery | Group-A |
| CatgutPatients went through suturing with catgut. | Procedure or surgery | Group-B |
Primary outcome
Post-operative pain
Time frame: 6 weeks
Pain was measured on the visual analog scale, with 0 as no pain, 1-3 as mild, 4-7 as moderate, and 8-10 as severe pain. Frequencies of all categories were noted.
Wound infection
Time frame: 6 weeks
The frequency of patients developing a wound infection was noted.
Wound dehiscence
Time frame: 6 weeks
The frequency of patients who experienced episiotomy wound ruptures and opened up along a surgical incision was noted.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 May 2026.
- Individual participant dataSharing planned: No. Data can be shared on a reasonable request.
Related trials for Episiotomy Wound
Active, not recruitingObservational study
Novosyn® Quick in Patients Undergoing Episiotomy Closure
Episiotomy Wound
Not yet recruiting
Perineal Protection Device for Reducing Perineal Trauma During Vaginal Delivery in First-time Mothers: a Multicenter Randomized Controlled Trial
Pelvic Floor Dysfunction, Perineal Laceration
Not yet recruiting
RELIEVE Study- Platelet-Rich Plasma to Reduce Postpartum Pain After Perineal Tears or Episiotomy
Perineal Trauma, Postpartum Pain
Not yet recruiting
Platelet-Rich Plasma Versus Standard Care for Episiotomy Wound Healing in Postpartum Women
Episiotomy, Platelet Rich Plasma (PRP)
Active, not recruiting
Comparison of the Flexibility of the Perineum in Primiparous Women Using the Medical Device Emagina During 90 Days of Their Pregnancy Compared to Those Having a Standard Pregnancy Follow-up
Pregnancy, Childbirth
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Komal Iqbal principal investigator
Sadiq Abbasi Hospital, Bahawalpur, Pakistan
Saba Nadeem, FCPS study director
Sadiq Abbasi Hospital, Bahawalpur, Pakistan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Absorbable synthetic suture and Catgut in people with Episiotomy Wound, run by Muhammad Aamir Latif at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Post-operative pain (time frame: 6 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2026.